Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

Germany flag Germany · Delayed Price · Currency is EUR
1.280
0.00 (0.00%)
At close: Jan 27, 2026
-14.67%
Market Cap7.02B -22.2%
Revenue (ttm)33.60B +3.0%
Net Income675.86M +40.2%
EPS0.18 +41.6%
Shares Outn/a
PE Ratio10.39
Forward PE11.54
Dividend0.05 (3.85%)
Ex-Dividend DateDec 29, 2025
Volumen/a
Average Volume110
Open1.280
Previous Close1.280
Day's Range1.280 - 1.280
52-Week Range1.160 - 1.520
Betan/a
RSI45.24
Earnings DateMar 31, 2026

About FRA:S1R

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1994
Employees 50,120
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol S1R
Full Company Profile

Financial Performance

In 2024, FRA:S1R's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial numbers in CNY Financial Statements